A cautionary lesson on the use of targeted methods for EGFR mutation analysis: a case report.


Epidermal growth factor receptor (EGFR) mutation analysis is recommended for lung cancer patients prior to the prescription of first-line EGFR tyrosine kinase inhibitors in order to predict response to treatment. There are many methods available to identify mutations in the EGFR gene; a large number of clinical laboratories use the therascreen EGFR RGQ PCR… (More)
DOI: 10.1136/jclinpath-2014-202313


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.